Electrodermal Activity (EDA): The Science of Skin Conductance and Emotional Arousal

I. Introduction to Electrodermal Activity (EDA)

Can your skin reveal your emotional state before you even feel it?

How might measuring this invisible signal reshape the way we study emotion, cognition, and mental health?

Electrodermal Activity (EDA), historically known as galvanic skin response (GSR), refers to changes in the skin’s electrical conductance caused by sweat secretion from eccrine sweat glands, primarily located on the palms and soles. These changes are governed by the sympathetic branch of the autonomic nervous system and are closely linked to emotional arousal, cognitive load, and attentional states.

Modern EDA devices apply a small, constant electrical voltage to the skin. The variation in conductance is measured through electrodes, offering researchers and clinicians an objective, continuous, and non-invasive measure of physiological arousal.

While EDA has its origins in thermoregulation research, it has become a central tool in psychophysiology, affective neuroscience, and behavioral science due to its sensitivity to moment-to-moment emotional and cognitive processes.

EDA is a window into the autonomic nervous system’s real-time response to emotionally salient stimuli whether threatening, exciting, or cognitively demanding.

II. The Physiology Behind EDA

EDA is driven by sweat gland activity, particularly in glabrous skin areas (hands and feet), which are densely innervated by sympathetic cholinergic fibers. Emotional stimuli activate the central autonomic network, involving structures like the amygdala, insula, anterior cingulate cortex, and hypothalamus, which then modulate sweat gland output via spinal pathways.

Key features:

• Eccrine sweat glands respond to emotional, not thermoregulatory, stimuli in EDA measurements.
• Sympathetic nervous system activity is solely responsible for the signal, making EDA a pure index of sympathetic arousal (Critchley, 2002).

This makes EDA particularly valuable for investigating emotion, stress, and attentional states, where parasympathetic involvement is minimal.

III. Emotional Arousal and Skin Conductance

Electrodermal activity (EDA) reflects the intensity, but not the valence, of an emotional response. This means both positive emotions (such as joy or excitement) and negative emotions (like fear or anxiety) produce increases in skin conductance. The magnitude of EDA change corresponds to emotional salience—the stronger the relevance or arousal of the stimulus, the higher the response (Salimpoor et al., 2009; Anders et al., 2004).

Because of its sensitivity to arousal, EDA is especially useful in various applied contexts, including:

• Media studies (to assess the emotional impact of advertisements or films)
• Clinical assessments (to monitor panic attacks or PTSD episodes)
• Neuroeconomic decision-making (to evaluate risk and reward responsiveness)

IV. Tonic and Phasic Components of the EDA Signal

EDA consists of two primary signal components, each revealing different aspects of autonomic activity.

1- Tonic activity, or Skin Conductance Level (SCL), represents the baseline level of skin conductance over longer time scales (seconds to minutes). It reflects general arousal or engagement, fluctuates slowly, and can be influenced by states such as fatigue, drowsiness, or sustained attention.

2- Phasic activity, or Skin Conductance Response (SCR), refers to rapid peaks in conductance following discrete stimuli, such as a sudden sound or emotionally evocative image. These responses typically occur within 1–5 seconds of the stimulus onset and return to baseline within 10–20 seconds (Benedek & Kaernbach, 2010). Phasic responses are the most widely studied component of EDA and serve as time-locked indicators of stimulus reactivity.

These phasic changes are the most widely studied aspect of EDA and serve as time-locked indicators of stimulus reactivity.

V. Event-Related and Spotaneous Responses

Modern EDA systems rely on precise sensor configurations to ensure accurate data collection. Most electrodes use silver-silver chloride (Ag/AgCl) interfaces due to their stability, low impedance, and biocompatibility. These are often paired with an ionic gel to enhance signal fidelity.

Common recording sites include the palmar (hand) or plantar (foot) surfaces, where sweat glands are most concentrated (van Dooren et al., 2012). EDA signals are measured in micro-Siemens (μS) and typically sampled at a rate of 1–10 Hz. Polarity is not meaningful in EDA, so only amplitude matters.

Device types range from research-grade systems (e.g., BIOPAC, Thought Technology) to wearables (e.g., Empatica E4, Shimmer GSR+). Trade-offs between mobility, signal quality, and resolution must be considered when choosing a platform.

VI. Clinical Applications of EDA Measurement

Electrodermal activity (EDA) serves as a valuable, non-invasive tool for assessing autonomic arousal patterns in a range of psychiatric conditions. Its sensitivity to sympathetic activation makes it particularly useful for evaluating disorders characterized by emotional dysregulation, hyperarousal, or emotional blunting.

Anxiety Disorders
Patients with anxiety-related disorders—including generalized anxiety disorder, panic disorder, and social anxiety disorder—frequently exhibit elevated phasic EDA responses to stress-inducing or anticipatory stimuli. These responses correlate strongly with subjective reports of anxiety intensity, providing an objective index of autonomic hyperreactivity. EDA can thus be employed to quantify baseline arousal and monitor changes in physiological reactivity across treatment sessions, supporting personalized and data-driven intervention strategies (Roth et al., 1990).

Post-Traumatic Stress Disorder (PTSD)
Individuals with PTSD often show both heightened tonic EDA (elevated skin conductance levels) and exaggerated stimulus-locked phasic responses, particularly when exposed to trauma-related cues. This physiological hyperarousal is consistent with core PTSD symptoms such as hypervigilance, exaggerated startle responses, and difficulty regulating affective states. EDA can aid clinicians in identifying specific emotional or contextual triggers, optimizing exposure-based therapies, and tracking autonomic recalibration throughout the therapeutic process (Pole, 2007).

Depression and Emotional Blunting
In contrast, depressive disorders, especially those involving anhedonia or emotional numbing, are often associated with attenuated EDA responses. This hypoarousal profile reflects reduced emotional engagement and may indicate broader deficits in affective processing. EDA monitoring can assist in differentiating subtypes of depression, evaluating treatment-related changes in emotional responsiveness, and targeting interventions aimed at reactivating affective networks (Sarchiapone et al., 2018).

VII. Predictive Utility and Intergration of EDA in Emotional Health

The Predictive Value of EDA in Emotional Health
Beyond its role as a real-time indicator of autonomic arousal, EDA holds significant potential as a predictive biomarker for emotional distress and psychiatric disorder onset. Longitudinal studies have demonstrated that elevated baseline skin conductance levels (SCL) or frequent spontaneous phasic responses may precede the clinical manifestation of anxiety disorders and PTSD. This predictive capacity allows for the early identification of at-risk individuals, providing a window for timely, preventive intervention strategies (Pole, 2007).

Integrating EDA into Therapeutic Practices
1- Biofeedback and Emotional Regulation
EDA biofeedback interventions train individuals to voluntarily modulate their skin conductance levels by providing real-time feedback on sympathetic activation. Through paced breathing, mindfulness, and attentional retraining, individuals learn to downregulate EDA responses during emotionally charged situations. Clinical trials have demonstrated improvements in emotional resilience, anxiety reduction, and enhanced autonomic regulation through EDA-based biofeedback training (Critchley et al., 2013).

2- Enhancing Psychotherapy Effectiveness
Therapists can integrate EDA monitoring into cognitive-behavioral therapy (CBT), exposure therapy, and trauma-focused interventions by identifying emotional triggers and evaluating real-time autonomic reactivity. This physiological data augments subjective reporting and enhances treatment precision, allowing for dynamic adjustment of session content based on moment-to-moment emotional states.

VII. Future Directions: Advancements in Wearable EDA Technology

Technological innovations in wearable psychophysiological monitoring have dramatically increased the feasibility of continuous EDA tracking in naturalistic settings. Devices now offer real-time, unobtrusive skin conductance recording, enabling a shift from episodic to longitudinal emotion monitoring. These platforms facilitate:

• Early detection of affective instability
• Personalized treatment adjustments in digital mental health
• In-situ biofeedback for self-regulation during daily life challenges

As these devices become increasingly integrated into mobile health (mHealth) platforms and remote clinical monitoring, they offer scalable, data-driven tools for precision psychiatry, preventive care, and adaptive therapy delivery.